Gut Microbiota

News Watch

We interviewed Prof. Joël Doré, Head of Research at the French National Institute for Agricultural Research (INRA - Institut National de la Recherche Agronomique), at the 2nd Gut Microbiota for Health Summit, in order to find out more about gut microbiota. Prof Doré’s interview includes an explanation on why we prefer the term ‘gut microbiota’ to ‘microflora’ or ‘gut flora’, when referring to…

GMFH Editing Team
GMFH Editing Team

We interviewed Prof. Joël Doré, Head of Research at the French National Institute for Agricultural Research (INRA - Institut National de la Recherche Agronomique), at the 2nd Gut Microbiota for Health Summit, in order to find out more about gut microbiota. Prof Doré’s interview includes an explanation on why we prefer the term ‘gut microbiota’ to ‘microflora’ or ‘gut flora’, when referring to…

GMFH Editing Team
GMFH Editing Team

Chocolate has a privileged place on the list of the most tempting foods. This food of the gods as tells its Latin name Theobroma cacao given by the noted Swedish nosologist Carl Linnaeus in 1753, has been ennobled in many countries around the globe as a curative drug, a culinary delight, and even a currency for commodity trading, retaining its…

GMFH Editing Team
GMFH Editing Team

Chocolate has a privileged place on the list of the most tempting foods. This food of the gods as tells its Latin name Theobroma cacao given by the noted Swedish nosologist Carl Linnaeus in 1753, has been ennobled in many countries around the globe as a curative drug, a culinary delight, and even a currency for commodity trading, retaining its…

GMFH Editing Team
GMFH Editing Team

We were in Madrid from 24th to 26th of February attending the 2nd Gut Microbiota for Health World Summit. The event gave us the opportunity to meet leading international experts and obtain information on the latest trends and findings in the field of gut microbiota. Diet, nutrition, lifestyle, environment, faecal transplantation, the immune system and different conditions (such as obesity,…

GMFH Editing Team
GMFH Editing Team

We were in Madrid from 24th to 26th of February attending the 2nd Gut Microbiota for Health World Summit. The event gave us the opportunity to meet leading international experts and obtain information on the latest trends and findings in the field of gut microbiota. Diet, nutrition, lifestyle, environment, faecal transplantation, the immune system and different conditions (such as obesity,…

GMFH Editing Team
GMFH Editing Team

If you took a microscope and zoomed on your intestine, you would find tens of trillions of bacteria that make up your gut microbiota. This community of microorganisms plays a key role in your health and wellbeing, as already reported on this blog, but it can also be affected by a range of external factors, including what we eat and…

GMFH Editing Team
GMFH Editing Team

If you took a microscope and zoomed on your intestine, you would find tens of trillions of bacteria that make up your gut microbiota. This community of microorganisms plays a key role in your health and wellbeing, as already reported on this blog, but it can also be affected by a range of external factors, including what we eat and…

GMFH Editing Team
GMFH Editing Team

As already mentioned on this blog, we are born sterile and our gut microbiota begins to develop at birth. We know that breast milk plays an essential role in the composition of gut microbiota in newborns. Spanish scientists from the Institute of Agrochemistry and Food Science (IATA - Instituto de Agroquímica y Tecnología de los Alimentos) and the Center for…

GMFH Editing Team
GMFH Editing Team

As already mentioned on this blog, we are born sterile and our gut microbiota begins to develop at birth. We know that breast milk plays an essential role in the composition of gut microbiota in newborns. Spanish scientists from the Institute of Agrochemistry and Food Science (IATA - Instituto de Agroquímica y Tecnología de los Alimentos) and the Center for…

GMFH Editing Team
GMFH Editing Team

Research & Practice

Previous research has shown that gut microbiota dysbiosis may be involved in the pathogenesis of ankylosing spondylitis (AS), which is a chronic inflammatory disease that mainly affects the sacroiliac joints and spine. However, the implications it could have for both local and systemic immune responses in AS has not yet been explored. A recent study, led by Dr. Giovanni Triolo…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown that gut microbiota dysbiosis may be involved in the pathogenesis of ankylosing spondylitis (AS), which is a chronic inflammatory disease that mainly affects the sacroiliac joints and spine. However, the implications it could have for both local and systemic immune responses in AS has not yet been explored. A recent study, led by Dr. Giovanni Triolo…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown that human gut microbial communities may be grouped into three types-called enterotypes-driven by high abundances of Bacteroides (enterotype 1), Prevotella (enterotype 2) and Ruminococcus (enterotype 3). Although gut microbiota may mediate the relationship between dietary habits and cardiovascular diseases, the role of enterotypes in understanding mechanisms linking dietary habits to cardiometabolic diseases has not been explored…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Previous research has shown that human gut microbial communities may be grouped into three types-called enterotypes-driven by high abundances of Bacteroides (enterotype 1), Prevotella (enterotype 2) and Ruminococcus (enterotype 3). Although gut microbiota may mediate the relationship between dietary habits and cardiovascular diseases, the role of enterotypes in understanding mechanisms linking dietary habits to cardiometabolic diseases has not been explored…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Gut microbiota dysbiosis, which has been defined as “the altered proportion and activity of bacterial groups of gut microbiota”, is suspected to be involved in several metabolic diseases such as hepatic steatosis, type 2 diabetes, and obesity. However, the underlying mechanisms are still a matter of debate. In a recent study, led by Dr. Matteo Serino from the Institut Nacional…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Gut microbiota dysbiosis, which has been defined as “the altered proportion and activity of bacterial groups of gut microbiota”, is suspected to be involved in several metabolic diseases such as hepatic steatosis, type 2 diabetes, and obesity. However, the underlying mechanisms are still a matter of debate. In a recent study, led by Dr. Matteo Serino from the Institut Nacional…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Faecal microbiota transplantation (FMT) is a therapy targeting the gut microbiome with the strongest evidence for efficacy in the treatment of recurrent Clostridium difficile infection. Although gut microbiota dysbiosis is involved in the pathogenesis of ulcerative colitis, the role of FMT as a therapy for it is still controversial as the two big randomised controlled trials done previously (here; here)…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Faecal microbiota transplantation (FMT) is a therapy targeting the gut microbiome with the strongest evidence for efficacy in the treatment of recurrent Clostridium difficile infection. Although gut microbiota dysbiosis is involved in the pathogenesis of ulcerative colitis, the role of FMT as a therapy for it is still controversial as the two big randomised controlled trials done previously (here; here)…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Hepatic encephalopathy is a brain dysfunction involving neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting with a severity that ranges from minor symptoms to coma. There have been reported differences in gut microbiota between those with and without hepatic encephalopathy. A previous Cochrane systematic review including 38 randomised clinical trials on non-absorbable disaccharides (lactulose and lactitol) versus…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Hepatic encephalopathy is a brain dysfunction involving neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting with a severity that ranges from minor symptoms to coma. There have been reported differences in gut microbiota between those with and without hepatic encephalopathy. A previous Cochrane systematic review including 38 randomised clinical trials on non-absorbable disaccharides (lactulose and lactitol) versus…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.